Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus
Open Access
- 1 May 1987
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 30 (5), 327-332
- https://doi.org/10.1007/bf00299026
Abstract
The conventional indirect immunofluorescence test of islet cell antibodies was recently improved by the development of a two-colour immunofluorescence assay using a monoclonal proinsulin antibody to detect islet B cells. The aim of this study was to test whether in this new assay the prevalence and titre of ICA were affected by the time of incubation carried out in the presence of aprotinin (Trasylol) as an inhibitor of proteolysis. The end-point titre of ICA was therefore determined in sera from 70 children aged 0.6 to 15 years with recent onset Type 1 (insulin-dependent) diabetes mellitus, 50 healthy control subjects and 97 non-diabetic siblings of Type 1 diabetic children. In the conventional twocolour assay, ICA was positive in 53/70 (76%) Type 1 diabetic patients, 1/50 control subjects and 2/97 siblings after 30 min incubation. Prolonged incubation for 18 h increased the prevalence of ICA positive samples to 62/70 (89%) in the diabetic patients and to 2/50 in the control subjects, while the prevalence among the siblings was unchanged. Of the ICA positive non-diabetic subjects, one control child has a father with Type 1 diabetes, and one of the siblings subsequently developed Type 1 diabetes. In the diabetic patients the median titre was 1:32 for the 30 min incubation, and it increased to 1:64 for the 18 h incubation (p<0.001). A marked prozone effect was seen; 16% of the samples from the Type 1 diabetic children sera were negative at a 1:2 dilution, but were found positive at higher dilutions. In conclusion, an 18 h incubation increases the end point titres and the prevalence of ICA in the two-colour ICA assay in Type 1 diabetic children of recent onset. The prevalence and levels of ICA among these patients may be larger than hitherto expected.Keywords
This publication has 24 references indexed in Scilit:
- VALUE OF INSULIN AUTOANTIBODIES AS SERUM MARKERS FOR INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1985
- IMPROVED SENSITIVITY OF ISLET CELL CYTOPLASMIC ANTIBODY ASSAY IN DIABETICSThe Lancet, 1984
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983
- EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUSThe Lancet, 1981
- COMPLEMENT-FIXING ISLET-CELL ANTIBODIES IN TYPE I DIABETES AND IN SUSCEPTIBLE PATIENTS WITH AUTOIMMUNE DISEASESThe Lancet, 1980
- COMPLEMENT-FIXING ISLET-CELL ANTIBODIES IN TYPE-I DIABETES: POSSIBLE MONITORS OF ACTIVE BETA-CELL DAMAGEThe Lancet, 1980
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUSThe Lancet, 1976
- ISLET-CELL ANTIBODIES IN JUVENILE DIABETES MELLITUS OF RECENT ONSETThe Lancet, 1975
- ANTIBODIES TO PANCREATIC ISLET CELLS IN INSULIN-DEPENDENT DIABETICS WITH COEXISTENT AUTOIMMUNE DISEASEThe Lancet, 1974
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974